We demonstrated that CTLA-4 expressed on breast cancer cells, mainly in the membrane of HCC1937 cell line, is functional and induces the activation of the MAP kinase pathway, while AKT signaling is abrogated. This evidence concerns the gene AKT1 and breast carcinoma.